These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11978612)
1. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Little RR; Tennill AL; Rohlfing C; Wiedmeyer HM; Khanna R; Goel S; Agrawal A; Madsen R; Goldstein DE Clin Chem; 2002 May; 48(5):784-6. PubMed ID: 11978612 [No Abstract] [Full Text] [Related]
2. Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Feldt-Rasmussen B Kidney Int; 2006 Oct; 70(8):1392-4. PubMed ID: 17024163 [TBL] [Abstract][Full Text] [Related]
3. Managing diabetes in hemodialysis patients: observations and recommendations. Shrishrimal K; Hart P; Michota F Cleve Clin J Med; 2009 Nov; 76(11):649-55. PubMed ID: 19884294 [TBL] [Abstract][Full Text] [Related]
4. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Freedman BI; Shenoy RN; Planer JA; Clay KD; Shihabi ZK; Burkart JM; Cardona CY; Andries L; Peacock TP; Sabio H; Byers JR; Russell GB; Bleyer AJ Perit Dial Int; 2010; 30(1):72-9. PubMed ID: 20056983 [TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio. Kalousová M; Sulková S; Zima T; Deppisch R; Beck W; Bednárová sV; Fortová M; Tesar V Ren Fail; 2003 Mar; 25(2):277-86. PubMed ID: 12739834 [TBL] [Abstract][Full Text] [Related]
6. The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients. Williams ME; Mittman N; Ma L; Brennan JI; Mooney A; Johnson CD; Jani CM; Maddux FW; Lacson E Hemodial Int; 2015 Oct; 19(4):562-71. PubMed ID: 25965145 [TBL] [Abstract][Full Text] [Related]
7. Agents for the treatment of diabetes mellitus. O'Mara NB Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919 [No Abstract] [Full Text] [Related]
8. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients]. Mácsai E; Rakk E; Miléder M; Fulcz A Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516 [TBL] [Abstract][Full Text] [Related]
9. [Glycosylated hemoglobin in chronic renal insufficiency. Case contribution]. De Cunto F; Confessore A; Corrado M; Maimone I; Palmieri F; Sapio C; Scarpino L; Venditti W; Mollica G Minerva Urol Nefrol; 1987; 39(4):433-6. PubMed ID: 3451383 [No Abstract] [Full Text] [Related]
10. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? Ichikawa H; Nagake Y; Takahashi M; Nakazono H; Kawabata K; Shikata K; Makino H Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):305-8. PubMed ID: 8741392 [TBL] [Abstract][Full Text] [Related]
11. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis. Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356 [TBL] [Abstract][Full Text] [Related]
12. Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea. Lee MJ; Kwon YE; Park KS; Kee YK; Yoon CY; Han IM; Han SG; Oh HJ; Park JT; Han SH; Yoo TH; Kim YL; Kim YS; Yang CW; Kim NH; Kang SW Medicine (Baltimore); 2016 Mar; 95(11):e3118. PubMed ID: 26986162 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus. Nakatsuka K; Hino M; Miki T; Nishizawa Y; Tabata T; Inoue T; Morii H Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828 [No Abstract] [Full Text] [Related]
14. Glycosylated hemoglobin in childhood renal disease and transplantation. O'Regan S; Prosmanne J; Letarte J; Bard H Int J Pediatr Nephrol; 1982 Mar; 3(1):17-20. PubMed ID: 7049978 [No Abstract] [Full Text] [Related]
15. Management of diabetes in patients with end-stage kidney disease. Zuber K JAAPA; 2012 Nov; 25(11):26-9. PubMed ID: 23620920 [No Abstract] [Full Text] [Related]
16. Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases. Inoue K; Goto A; Kishimoto M; Tsujimoto T; Yamamoto-Honda R; Noto H; Kajio H; Terauchi Y; Noda M Clin Exp Nephrol; 2015 Dec; 19(6):1179-83. PubMed ID: 25824109 [TBL] [Abstract][Full Text] [Related]
17. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Williams ME; Lacson E; Teng M; Ofsthun N; Lazarus JM Kidney Int; 2006 Oct; 70(8):1503-9. PubMed ID: 16941022 [TBL] [Abstract][Full Text] [Related]
19. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H Nephron; 1992; 61(2):181-6. PubMed ID: 1630543 [TBL] [Abstract][Full Text] [Related]
20. Effect of glycemic control on intact parathyroid hormone level in end stage renal disease patients on maintenance hemodialysis. Dan S; Aditya P; Samanta M; Jothimalar R; Soundarajan P Diabetes Res Clin Pract; 2014 Sep; 105(3):352-5. PubMed ID: 25015316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]